CVS Health (CVS) Tops Q3 EPS by 44c, Beats on Revenue; Offers FY26 EPS Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
- Qualcomm (QCOM) Reports In-Line Q4 EPS, Beats on Revenue; Offers Q1 Guidance
- Intel shares fall as competitor reports record results
- Array Technologies and Shoals Technologies agree to stock-for-stock merger
- AMD gets bullish pre-earnings call from Lynx as server CPU demand accelerates
- SanDisk shares fall on election and chip sector pressure
- After-Hours Movers: QCOM, COHR, APP, HUBS, SNAP, FSLY, FIG, ZG, BROS, CDE
- After-Hours Movers: AMD, SMCI, SWKS, NRIX, TOST, BKNG
- After-Hours Movers: AMZN, TWLO, INTC, SNDK, RDDT, RBLX, PINS, RIVN, SBUX, ILMN
- After-Hours Movers: GOOGL, MSFT, NOW, KLAC. CMG, CVNA, TDOC
- After-Hours Movers: STX, ENPH, HOOD, V, CSGP, BOOM, CAKE, PPG, OI, TER
CVS Health Announces Intent to Create Two Distinct Leaders in Healthcare
November 4, 2026 6:31 AM ESTA leading healthcare solutions company with health benefits, pharmacy services and care delivery The leading national retail pharmacy and community healthcare company Ongoing strategic execution creates opportunity for CVS Health to evolve into two companies with greater focus and more value for stakeholders Will continue to improve affordability, access, and simplicity in healthcare Both companies expected to have a solid investment grade rating, with strong free cash flow... More
CVS HEALTH CORPORATION REPORTS THIRD QUARTER 2026 RESULTS AND RAISES FULL-YEAR 2026 GUIDANCE
November 4, 2026 6:30 AM ESTThird quarter total revenues increased to $108.4 billion, up 5.4% year-over-year Third quarter GAAP diluted EPS of $1.68 and Adjusted EPS of $2.09 Generated year-to-date cash flow from operations of $15.3 billion Raising full-year 2026 guidance:GAAP diluted EPS guidance to at least $6.98 from a range of $6.84 to $7.04Adjusted EPS guidance to at least $8.20 from a range of $7.90 to $8.10Cash flow from operations guidance to at least $15.5 billion from at... More



